These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15306769)

  • 21. Can the immune system fight Alzheimer disease?
    Hyman BT; Growdon JH
    Nat Med; 2006 Jul; 12(7):755-6; discussion 756. PubMed ID: 16829929
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunization for Alzheimer's disease: yet closer to clinical trials.
    Gurwitz D
    Trends Mol Med; 2001 Sep; 7(9):385. PubMed ID: 11530319
    [No Abstract]   [Full Text] [Related]  

  • 23. 12th international conference on Alzheimer's disease. Part 2. 11-16 July 2009, Vienna, Austria.
    Filson S
    IDrugs; 2009 Sep; 12(9):537-8. PubMed ID: 19697268
    [No Abstract]   [Full Text] [Related]  

  • 24. Into the darkness of the mind.
    Underwood A
    Newsweek; 2003 Dec; 142(23):90, 92. PubMed ID: 14712575
    [No Abstract]   [Full Text] [Related]  

  • 25. [Abeta vaccination and treatment of Alzheimer's disease].
    Takeda K; Hara H
    No To Shinkei; 2005 Oct; 57(10):867-76. PubMed ID: 16277231
    [No Abstract]   [Full Text] [Related]  

  • 26. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME; Gouras G; Relkin NR; Szabo P
    Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of anti-Abeta vaccination as a promising therapy for Alzheimer's disease.
    Okura Y; Matsumoto Y
    Drug News Perspect; 2007; 20(6):379-86. PubMed ID: 17925892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active immunization against Alzheimer's beta-amyloid peptide using phage display technology.
    Solomon B
    Vaccine; 2007 Apr; 25(16):3053-6. PubMed ID: 17287054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization therapy in Alzheimer's disease.
    Mor F; Monsonego A
    Expert Rev Neurother; 2006 May; 6(5):653-9. PubMed ID: 16734513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of Alzheimer's disease].
    Ishiura S; Hattori C
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(14):2179-85. PubMed ID: 15559301
    [No Abstract]   [Full Text] [Related]  

  • 31. Active immunization trial in Abeta42-injected P301L tau transgenic mice.
    Kulic L; Kurosinski P; Chen F; Tracy J; Mohajeri MH; Li H; Nitsch RM; Götz J
    Neurobiol Dis; 2006 Apr; 22(1):50-6. PubMed ID: 16289870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
    Solomon B
    Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microglia as a potential bridge between the amyloid beta-peptide and tau.
    Kitazawa M; Yamasaki TR; LaFerla FM
    Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis.
    Lee EB; Leng LZ; Lee VM; Trojanowski JQ
    FEBS Lett; 2005 May; 579(12):2564-8. PubMed ID: 15862291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which is a better target for AD immunotherapy, A beta or tau?
    Martin-Jones Z; Lasagna-Reeves C
    Alzheimer Dis Assoc Disord; 2008; 22(2):111-2. PubMed ID: 18525281
    [No Abstract]   [Full Text] [Related]  

  • 36. Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease.
    Masliah E; Hansen L; Adame A; Crews L; Bard F; Lee C; Seubert P; Games D; Kirby L; Schenk D
    Neurology; 2005 Jan; 64(1):129-31. PubMed ID: 15642916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-amyloid antibody drugs in clinical testing for Alzheimer's disease.
    Bednar MM
    IDrugs; 2009 Sep; 12(9):566-75. PubMed ID: 19697276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-amyloid immunisation in Alzheimer's disease.
    Sorbi S
    Neurol Sci; 2005 May; 26 Suppl 1():S5. PubMed ID: 15883696
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V; Steinitz M
    Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
    Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.